Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-23-005046

Chief Operating Officer gave up 4,671 shares (to pay taxes)

  • Chief Operating Officer acquired 11,248 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

BILINSKY IGOR · Chief Operating Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-01-17 Exercise or conversion : show line 1 in the form +11,248 29,049 D
2023-01-17 Shares withheld for taxes : show line 2 in the form −4,671 $6.43 $30,035 24,378 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-01-17 Exercise or conversion : show line 3 in the form Restricted Stock Units −11,248 22,502 D
Loading xslF345X03/tm233853d2_4seq1.xml…